Type of inducing signal regulates transactivation by p53

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1358, Issue 3, 1997, Pages 314-320

  Borner, Markus M ^a   Joncourt, Franziska ^a   Hotz, Michel A ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Apoptosis; DNA damage; p53; Proliferation; Transactivation; waf1

Indexed keywords

CLADRIBINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHYTOHEMAGGLUTININ; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; CONTROLLED STUDY; GENE ACTIVATION; GROWTH DISORDER; HUMAN; HUMAN CELL; IN VITRO STUDY; MONONUCLEAR CELL; NORMAL HUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSACTIVATION;

APOPTOSIS; CELL CYCLE; CELLS, CULTURED; CLADRIBINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME INHIBITORS; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; NUCLEAR PROTEINS; PHYTOHEMAGGLUTININS; POLY(ADP-RIBOSE) POLYMERASES; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030730629     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4889(97)00059-1     Document Type: Article

References (28)

1. Lane D.P. Nature. 358:1992;15-16.
2. Vogelstein B., Kinzler K.W. Cell. 70:1992;523-526.
3. El-Deiry W., Harper J., O'Connor P., Velculescu V.E., Canman C., Jackman J., Pietenpol J., Burrell M., Hill D., Wang Y., Wiman K., Mercer W., Kastan M., Kohn K., Elledge S., Kinzler K., Vogelstein B. Cancer Res. 54:1994;1169-1174.
4. Ashkenas J., Werb Z. J. Exp. Med. 183:1996;1947-1951.
5. El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. Cell. 75:1993;817-825.
6. Price B., Park S. Cancer Res. 54:1994;896-899.
7. Miyashita T., Reed J. Cell. 80:1995;293-299.
8. Waga S., Hannon G., Beach D., Stillman B. Nature. 369:1994;574-578.
9. Michieli P., Chedid M., Lin D., Pierce J., Mercer W., Givol D. Cancer Res. 54:1994;3391-3395.
10. Deng C., Zhang P., Harper J., Elledge S., Leder P. Cell. 82:1995;675-684.
11. Momand J., Zambetti G.P., Olson D.C., George D., Levine A.J. Cell. 69:1992;1237-1245.
12. Chen C.-Y., Oliner J., Zhan Q., Fornace A., Vogelstein B., Kastan M. Proc. Natl. Acad. Sci. USA. 91:1994;2684-2688.
13. Voelkerding K., Steffen D., Zaidi S., Malter J. Oncogene. 10:1995;515-521.
14. Reed J., Alpers J., Nowell P., Hoover R. Proc. Natl. Acad. Sci. USA. 83:1986;3982-3986.
15. Saven A., Piro L. Ann. Intern. Med. 120:1994;784-791.
16. Seto S., Carrera C., Kubota M., Wasson D., Carson D. J. Clin. Invest. 75:1985;377-383.
17. Borner M., Myers C., Sartor O., Sei Y., Toko T., Trepel J., Schneider E. Cancer Res. 55:1995;2122-2128.
18. Oliner J.D., Kinzler K.W., Meltzer P.S., George D.L., Vogelstein B. Nature. 358:1992;80-83.
19. Darzynkiewicz Z., Bruno S., Bino G.D., Gorczyca W., Hotz M.A., Lassota P., Traganos F. Cytometry. 13:1992;795-808.
20. Evan G.I., Wyllie A.H., Gilbert C.S., Littlewood T.D., Land H., Brooks M., Waters C.M., Penn L.Z., Hancock D.C. Cell. 69:1992;119-128.
21. Casciola-Rosen L., Nicholson D., Chong T., Rowan K., Thornberry N., Miller D., Rosen A. J. Exp. Med. 183:1996;1957-1964.
22. Mosner J., Deppert W. Oncogene. 9:1994;3321-3328.
23. Guillouf C., Grana X., Selvakumaran M., De Luca A., Giordano A., Hoffman B., Liebermann D. Blood. 85:1995;2691-2698.
24. Lu X., Burbidge S., Griffin S., Smith H. Oncogene. 13:1996;413-418.
25. Bhatia K., Kang V., Stein G., Bustin M., Cherney B., Notario V., Haque S., Huppi K., Smulson M. J. Cell. Physiol. 144:1990;345-353.
26. Whitacre C., Hashimoto H., Tsai M.-L., Chatterjee S., Berger S., Berger N. Cancer Res. 55:1995;3697-3701.
27. Lazebnik Y., Kaufmann S., Desnoyers S., Poirier G., Earnshaw W. Nature. 371:1994;346-347.
28. Schlegel J., Peters I., Orrenius S., Miller D., Thornberry N., Yamin T., Nicholson D. J. Biol. Chem. 271:1996;1841-1844.